Collagen Matrix Gains FDA Clearance for Bioactive Moldable Bone Graft Matrix
Collagen Matrix received FDA 510(k) clearance to market OssiMend® Bioactive Moldable Bone Graft Matrix. Apr 12, 2019
BONESUPPORT: Study Affirms Cerament Remodels into Human Bone
Retrospective review of 163 patients at one-year follow-up revealed clinical evidence of BONESUPPORT's CERAMENT® bone void filler remodeling into bone in humans. Apr 11, 2019
NuVasive Debuts X360 System for Lateral Single-Position Spine Procedures
NuVasive is introducing the X360 system integrated with Pulse automation for lateral single-position surgery. Apr 11, 2019
HAPPE Spine Announces Second Financing Round
HAPPE Spine received a second round of financing. The company is developing material technology that allows for the construction of partial or fully porous hydroxyapatite-reinforced PEEK implants. Apr 11, 2019
Barricaid Completes $52MM Financing to Support Barricaid
Intrinsic Therapeutics completed a US $52MM equity financing. Proceeds will support U.S. commercialization of the Barricaid® anular closure device. Apr 11, 2019
Treace Medical: Lapiplasty 3D Bunion Correction Study Results
Treace Medical Concepts announced additional positive clinical data supporting the Lapiplasty® 3D Bunion Correction procedure. Apr 09, 2019
Osso VR Surgical Training Expands to Europe
Osso VR announced expansion to the European market following adoption of its virtual reality surgical training platform in the U.K. Apr 09, 2019
Alphatec Secures Additional $30MM Funding
Alphatec will receive US $30MM in secured debt financing from Squadron Capital. Proceeds will support company growth. Apr 09, 2019
Medacta Group SA Prices IPO at CHF 96 (USD $96.1) Per Share
Medacta launches IPO with base size of CHF 547MM (USD $547.8MM), with 5.7 million shares offered at a price of CHF 96 (USD $96.1). Apr 05, 2019
Orthofix M6-C Artificial Cervical Disc Study: Full 2-Year Data
Full 2-year outcomes from a U.S. IDE study of Orthofix Medical's M6-C artificial cervical disc demonstrated that disc replacement with the device is not inferior to treatment with ACDF. Apr 04, 2019
